Clinical Protocol & Results
✅ Subjects: 24 healthy adults (12M/12F),single-dose 8mg astaxanthin
✅ Test Formulation: Phospholipid-basedmicrocapsules (mean particle size: 80nm)
✅ Control: Standard astaxanthin oilsuspension
Key Outcomes:
▶️ 28x Higher Peak Plasma(C<sub>max</sub>)
→ 423 ng/mL vs151 ng/mL (p<0001)
▶️ Extended Half-Life(T<sub>max</sub>)
→ Sustainedrelease over 24h (vs 8h control)
▶️ AUC<sub>0-48h</sub>Increased 31x
→ 687 ng·h/mL vs 222 ng·h/mL (p<0001)
▶️ Reduced Inter-Individual Variability:
→ CV% ↓ from 38% to 12% → ensures consistent efficacy
Mechanistic Advantage:
Microcapsules protect astaxanthin fromgastric degradation and utilize lymphatic uptake pathways via phospholipidbilayer fusion with enterocytes
Formulation Applications:
•High-PotencySupplements: Achieve clinical efficacy at lower doses
•Beauty-from-Within:Enhanced skin antioxidant protection (validated by ↓ plasma MDA levels)
•SportsNutrition: Accelerated muscle recovery via systemic ROS reduction
Blue Eyes Biotech CO, Ltd MastersBioavailability Engineering:
Nano-Microencapsulation Platform:
- Lipid matrix (sunflowerphosphatidylcholine + MCT)
- Cold-process encapsulation (>95%astaxanthin retention)
Natural & Stable:
- Non-GMO Haematococcus pluvialissource
- 18-month stability (40°C/75% RHtesting)
✅ Certified Quality:
- ISO 22000, FSSC 22000, Halal/Kosher
Procurement Advantages:
→Human PKData Included: Accelerates regulatory submissions (EFSA/FDA)
→DiverseFormats: Powder for capsules, liquid for softgels, water-dispersible forbeverages
→CompleteDossier: Bioavailability study, stability reports, safety certifications(GRAS)
Maximize Your Product’s Antioxidant Impact:
Request PK study whitepaper & freesample kits:
[email protected] | www.blueeyes-bio.com